301 related articles for article (PubMed ID: 25076336)
1. Radioembolization in the treatment of neuroendocrine tumors of the pancreas.
John PK; Saif MW
JOP; 2014 Jul; 15(4):332-4. PubMed ID: 25076336
[TBL] [Abstract][Full Text] [Related]
2. Arterial therapies of non-colorectal cancer metastases to the liver (from chemoembolization to radioembolization).
Hoffmann RT; Paprottka P; Jakobs TF; Trumm CG; Reiser MF
Abdom Imaging; 2011 Dec; 36(6):671-6. PubMed ID: 21584635
[TBL] [Abstract][Full Text] [Related]
3. Intra-arterial therapy of neuroendocrine tumour liver metastases: comparing conventional TACE, drug-eluting beads TACE and yttrium-90 radioembolisation as treatment options using a propensity score analysis model.
Do Minh D; Chapiro J; Gorodetski B; Huang Q; Liu C; Smolka S; Savic LJ; Wainstejn D; Lin M; Schlachter T; Gebauer B; Geschwind JF
Eur Radiol; 2017 Dec; 27(12):4995-5005. PubMed ID: 28677067
[TBL] [Abstract][Full Text] [Related]
4. Role of interventional radiology in the treatment of patients with neuroendocrine metastases in the liver.
Kvols LK; Turaga KK; Strosberg J; Choi J
J Natl Compr Canc Netw; 2009 Jul; 7(7):765-72. PubMed ID: 19635229
[TBL] [Abstract][Full Text] [Related]
5. 90Y Radioembolization for metastatic neuroendocrine liver tumors: preliminary results from a multi-institutional experience.
Rhee TK; Lewandowski RJ; Liu DM; Mulcahy MF; Takahashi G; Hansen PD; Benson AB; Kennedy AS; Omary RA; Salem R
Ann Surg; 2008 Jun; 247(6):1029-35. PubMed ID: 18520231
[TBL] [Abstract][Full Text] [Related]
6. [Two cases of neuroendocrine tumors of the pancreas with multiple liver metastases treated by use of degradable starch microspheres and octreotide].
Goto W; Shimizu S; Kotsuka M; Sakae M; Kanazawa A; Tsukamoto T; Yamashita Y; Nishiguchi Y
Gan To Kagaku Ryoho; 2014 Nov; 41(12):2139-41. PubMed ID: 25731449
[TBL] [Abstract][Full Text] [Related]
7. Clinical Analysis and Comprehensive Treatment of Nonfunctional Pancreatic Neuroendocrine Tumor With Liver Metastases: A Retrospective Single-Center Study.
Xu X; Han X; Liu L; Ji Y; Li J; Lou W
Pancreas; 2015 Aug; 44(6):995-6. PubMed ID: 26166471
[No Abstract] [Full Text] [Related]
8. Management of pancreatic neuroendocrine tumors.
Dickson PV; Behrman SW
Surg Clin North Am; 2013 Jun; 93(3):675-91. PubMed ID: 23632152
[TBL] [Abstract][Full Text] [Related]
9. Lung Shunt Fraction prior to Yttrium-90 Radioembolization Predicts Survival in Patients with Neuroendocrine Liver Metastases: Single-Center Prospective Analysis.
Ludwig JM; Ambinder EM; Ghodadra A; Xing M; Prajapati HJ; Kim HS
Cardiovasc Intervent Radiol; 2016 Jul; 39(7):1007-14. PubMed ID: 26964779
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic strategies for neuroendocrine liver metastases.
Frilling A; Clift AK
Cancer; 2015 Apr; 121(8):1172-86. PubMed ID: 25274401
[TBL] [Abstract][Full Text] [Related]
11. Management of advanced neuroendocrine tumors with hepatic metastasis.
Khasraw M; Gill A; Harrington T; Pavlakis N; Modlin I
J Clin Gastroenterol; 2009 Oct; 43(9):838-47. PubMed ID: 19654558
[TBL] [Abstract][Full Text] [Related]
12. Management of well-differentiated gastrointestinal neuroendocrine tumors metastatic to the liver.
Wang SC; Fidelman N; Nakakura EK
Semin Oncol; 2013 Feb; 40(1):69-74. PubMed ID: 23391114
[TBL] [Abstract][Full Text] [Related]
13. The efficacy of hepatic 90Y resin radioembolization for metastatic neuroendocrine tumors: a meta-analysis.
Devcic Z; Rosenberg J; Braat AJ; Techasith T; Banerjee A; Sze DY; Lam MG
J Nucl Med; 2014 Sep; 55(9):1404-10. PubMed ID: 25012459
[TBL] [Abstract][Full Text] [Related]
14. Salvage therapy for liver-dominant colorectal metastatic adenocarcinoma: comparison between transcatheter arterial chemoembolization versus yttrium-90 radioembolization.
Hong K; McBride JD; Georgiades CS; Reyes DK; Herman JM; Kamel IR; Geschwind JF
J Vasc Interv Radiol; 2009 Mar; 20(3):360-7. PubMed ID: 19167245
[TBL] [Abstract][Full Text] [Related]
15. GEP-NETS update: Interventional radiology: role in the treatment of liver metastases from GEP-NETs.
de Baere T; Deschamps F; Tselikas L; Ducreux M; Planchard D; Pearson E; Berdelou A; Leboulleux S; Elias D; Baudin E
Eur J Endocrinol; 2015 Apr; 172(4):R151-66. PubMed ID: 25385817
[TBL] [Abstract][Full Text] [Related]
16. Radioembolization with yttrium-90 resin microspheres for neuroendocrine tumor liver metastases.
Peker A; Çiçek O; Soydal Ç; Küçük NÖ; Bilgiç S
Diagn Interv Radiol; 2015; 21(1):54-9. PubMed ID: 25430526
[TBL] [Abstract][Full Text] [Related]
17. Radioembolization of colorectal hepatic metastases using yttrium-90 microspheres.
Mulcahy MF; Lewandowski RJ; Ibrahim SM; Sato KT; Ryu RK; Atassi B; Newman S; Talamonti M; Omary RA; Benson A; Salem R
Cancer; 2009 May; 115(9):1849-58. PubMed ID: 19267416
[TBL] [Abstract][Full Text] [Related]
18. Hepatectomy After Yttrium-90 (Y90) Radioembolization-Induced Liver Fibrosis.
Maker AV; August C; Maker VK; Weisenberg E
J Gastrointest Surg; 2016 Apr; 20(4):869-70. PubMed ID: 26847353
[TBL] [Abstract][Full Text] [Related]
19. Yttrium-90 radioembolization for unresectable metastatic neuroendocrine liver tumor: A systematic review.
Jia Z; Wang W
Eur J Radiol; 2018 Mar; 100():23-29. PubMed ID: 29496075
[TBL] [Abstract][Full Text] [Related]
20. Interventional treatment of neuroendocrine liver metastases.
Knigge U; Hansen CP; Stadil F
Surgeon; 2008 Aug; 6(4):232-9. PubMed ID: 18697366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
